Gerresheimer (GXI) PT Set at €82.00 by Credit Suisse Group
Gerresheimer (ETR:GXI) has been given a €82.00 ($95.35) price target by stock analysts at Credit Suisse Group in a research report issued on Thursday. The firm presently has a “buy” rating on the stock. Credit Suisse Group’s price target would indicate a potential upside of 31.83% from the stock’s previous close.
Other analysts have also recently issued reports about the company. Independent Research set a €66.00 ($76.74) price objective on Gerresheimer and gave the company a “neutral” rating in a research note on Thursday. Berenberg Bank set a €81.00 ($94.19) price objective on Gerresheimer and gave the company a “buy” rating in a research note on Thursday. JPMorgan Chase & Co. set a €49.50 ($57.56) price objective on Gerresheimer and gave the company a “sell” rating in a research note on Tuesday. Goldman Sachs Group set a €65.00 ($75.58) price objective on Gerresheimer and gave the company a “neutral” rating in a research note on Monday, February 11th. Finally, Deutsche Bank set a €86.00 ($100.00) price objective on Gerresheimer and gave the company a “buy” rating in a research note on Tuesday, January 15th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of €68.23 ($79.33).
GXI opened at €62.20 ($72.33) on Thursday. Gerresheimer has a 52 week low of €59.97 ($69.73) and a 52 week high of €78.25 ($90.99).
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Recommended Story: Fiduciary
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.